Medco Energi Internasional, ID1000053705

Fitch calls Kutei purchase credit neutral for Medco Energi Internasional stock

Published on 10/19/2026 at 10:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fitch calls Medco's Kutei deal neutral on October 18, 2026. Medco Energi Internasional stock costs EUR 0.06 during trading on October 19, 2026.

Credit view and operating milestones

Fitch called the proposed Kutei purchase credit neutral on October 18, 2026.
First-half revenue reached USD 1.415 billion on September 21, 2026.
Medco Energi Internasional stock traded at EUR 0.06 at 10:38 a.m. CEST at Lang & Schwarz on October 19, 2026.
BRI Danareksa raised its target from IDR 2,200 to IDR 2,300 on October 7, 2026.

Medco Energi Internasional, ID1000053705, Illustration mit AI erstellt.

Medco Energi Internasional (ISIN ID1000053705) was trading at EUR 0.06 at Lang & Schwarz on October 19, 2026 at 10:38 a.m. CEST. Fitch Ratings said on October 18, 2026 that Medco's proposed purchase of a 10 percent interest in four Kutei Basin production-sharing contracts is credit neutral.

Kutei deal adds gas exposure

The transaction covers the Muara Bakau, Ganal, West Ganal and East Ganal contracts in East Kalimantan. The agreement remains subject to regulatory approval, so the announcement establishes an expansion plan rather than a completed transfer.

Fitch expects Medco's consolidated net debt-to-EBITDA ratio to rise from 2.5 times at the end of 2025 to about 3.0 times in 2028. The rating agency still places that forecast below its 3.3 times negative-sensitivity threshold, while the assets add more than 1.3 trillion cubic feet of gas in place.

What does the earnings base show?

Medco entered the Kutei transaction after a stronger first half. In its September 21, 2026 results release, FinancialFilings reported revenue of USD 1.415 billion, EBITDA of USD 805 million and net income attributable to owners of USD 275 million for the first half of 2026. Oil and gas production reached 170 thousand barrels of oil equivalent per day, while cash production costs were USD 8.40 per barrel of oil equivalent.

The company maintained 2026 production guidance of 165,000 to 170,000 barrels of oil equivalent per day and raised oil and gas capital expenditure guidance to USD 450 million to USD 475 million. Sakakemang first gas remains targeted for the third quarter of 2027.

Three dated company milestones

On September 21, 2026, Medco reported first-half revenue of USD 1.415 billion and net income of USD 275 million through FinancialFilings. On October 7, 2026, BRI Danareksa raised its target from IDR 2,200 to IDR 2,300, according to Investortrust.id. On October 18, 2026, Fitch described the proposed Kutei purchase as credit neutral.

Next dates for the portfolio

The Kutei transaction is targeted for completion by the end of 2026, subject to approvals. Medco also targets first gas from Sakakemang in the third quarter of 2027, according to the first-half results release.

Stock trades at EUR 0.06

Medco's Indonesian listing closed at IDR 1,250 on October 19, 2026, after a 3.10 percent decline in the finance quote, while its market capitalization was IDR 30.9 trillion. The Indonesia Stock Exchange listing gives German investors a euro reference through Lang & Schwarz, but the operating figures remain reported in USD.

Medco Energi Internasional was trading at EUR 0.06 at Lang & Schwarz on October 19, 2026 at 10:38 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Medco Energi Internasional stock.